chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Echocardiogram abnormal, Electrocardiogram normal, Endotracheal intubation, Epidural haemorrhage
Clinical narrative: Patient is an 80 y/o right handed female who is totally independent at baseline who received her Pfizer vaccine out of the country (1st dose 2/19/21, 2nd dose 3/12/21).  She was reactive to both shots, reporting arthralgias, headache, low grade fever, chills. She had a rise in blood pressure later during the day of her shot as well as the next day (up to 180/70, from baseline of 130/70). She also had an episode of epistaxis several days after her first shot.  She traveled independently out of the country on 3/31/21 to visit her son on a leisure trip. On 4/5/21 she had headache, dizziness/lightheadedness, and did not feel well, and her systolic BP was 198, after which she took additional 40 mg of lisinopril.   Her BP subsequently decreased to systolic BP of 130 mm Hg on 4/5/21, but over the next few days she had labile BP with a range of BP of 125 to 171/ 58 - 68.  She was meticulous in checking and recording her BP several times a day, and she increased her lisinopril dose to 40 mg po qd from 20 mg po qd given the higher than usual blood pressure range.  On 4/10/21 her BP was as follows: 6:30 am, 148/60 (she took her daily lisinopril 20 mg po); 11:30 am:  132/52; 3 pm: 171/69 (she took additional lisinopril 20 mg po) after which her systolic BP decreased to 130. Then around 6:20 pm the same day (4/10/21), she had acute onset of headache, vomiting, left sided weakness, SBP 220, and was witnessed to have rapid change in mental status. There was no antecedent trauma to the head. EMTs were called immediately and she had loss of consciousness during the ambulance ride to the ED, after about 20 minutes of symptom onset, with agonal breathing and bradycardia to the 40s, but never lost her pulse. Upon arrival to the ED out of the country, her Glascow Coma Scale (GCS) was 6, she was rapidly intubated and stabilized. Head CT demonstrated massive intraparenchymal hemorrhage (140 cc) within the R temporal parietal and occipital lobes, with cerebral edema and 14 mm midline shift, associated with small subdural hematoma and small intraventricular hemorrhage within the temporal horn and body of the R lateral ventricle. They reported hyperdense "spot sign" within the intraparenchymal hematoma compatible with active hemorrhage, no evidence of venous thrombosis, no masses, no arteriovenous malformations. She had 2.5 mm aneurysm right  that was thought to be incidental finding unrelated to her event. She was taken emergently to the OR on 4/10/2021 for decompressive R hemicraniectomy, which she underwent successfully with minimal blood loss.  She had no coagulopathy and her platelets and hemoglobin were normal. She remained in the Neuro ICU for 3 weeks. She received a tracheostomy two weeks after her presentation, and was weaned off the ventilator. She is breathing spontaneously after 5 weeks from presentation. She remains in coma or minimally conscious state, with GCS score of 5-6 as of 5/13/2021.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Epistaxis, Glomerular filtration rate normal, Haemoglobin decreased, Headache, Hemiparesis
Clinical narrative: Patient is an 80 y/o right handed female who is totally independent at baseline who received her Pfizer vaccine out of the country (1st dose 2/19/21, 2nd dose 3/12/21).  She was reactive to both shots, reporting arthralgias, headache, low grade fever, chills. She had a rise in blood pressure later during the day of her shot as well as the next day (up to 180/70, from baseline of 130/70). She also had an episode of epistaxis several days after her first shot.  She traveled independently out of the country on 3/31/21 to visit her son on a leisure trip. On 4/5/21 she had headache, dizziness/lightheadedness, and did not feel well, and her systolic BP was 198, after which she took additional 40 mg of lisinopril.   Her BP subsequently decreased to systolic BP of 130 mm Hg on 4/5/21, but over the next few days she had labile BP with a range of BP of 125 to 171/ 58 - 68.  She was meticulous in checking and recording her BP several times a day, and she increased her lisinopril dose to 40 mg po qd from 20 mg po qd given the higher than usual blood pressure range.  On 4/10/21 her BP was as follows: 6:30 am, 148/60 (she took her daily lisinopril 20 mg po); 11:30 am:  132/52; 3 pm: 171/69 (she took additional lisinopril 20 mg po) after which her systolic BP decreased to 130. Then around 6:20 pm the same day (4/10/21), she had acute onset of headache, vomiting, left sided weakness, SBP 220, and was witnessed to have rapid change in mental status. There was no antecedent trauma to the head. EMTs were called immediately and she had loss of consciousness during the ambulance ride to the ED, after about 20 minutes of symptom onset, with agonal breathing and bradycardia to the 40s, but never lost her pulse. Upon arrival to the ED out of the country, her Glascow Coma Scale (GCS) was 6, she was rapidly intubated and stabilized. Head CT demonstrated massive intraparenchymal hemorrhage (140 cc) within the R temporal parietal and occipital lobes, with cerebral edema and 14 mm midline shift, associated with small subdural hematoma and small intraventricular hemorrhage within the temporal horn and body of the R lateral ventricle. They reported hyperdense "spot sign" within the intraparenchymal hematoma compatible with active hemorrhage, no evidence of venous thrombosis, no masses, no arteriovenous malformations. She had 2.5 mm aneurysm right  that was thought to be incidental finding unrelated to her event. She was taken emergently to the OR on 4/10/2021 for decompressive R hemicraniectomy, which she underwent successfully with minimal blood loss.  She had no coagulopathy and her platelets and hemoglobin were normal. She remained in the Neuro ICU for 3 weeks. She received a tracheostomy two weeks after her presentation, and was weaned off the ventilator. She is breathing spontaneously after 5 weeks from presentation. She remains in coma or minimally conscious state, with GCS score of 5-6 as of 5/13/2021.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heparin-induced thrombocytopenia test, Intensive care, International normalised ratio normal, Intracranial aneurysm, Intracranial haematoma
Clinical narrative: Patient is an 80 y/o right handed female who is totally independent at baseline who received her Pfizer vaccine out of the country (1st dose 2/19/21, 2nd dose 3/12/21).  She was reactive to both shots, reporting arthralgias, headache, low grade fever, chills. She had a rise in blood pressure later during the day of her shot as well as the next day (up to 180/70, from baseline of 130/70). She also had an episode of epistaxis several days after her first shot.  She traveled independently out of the country on 3/31/21 to visit her son on a leisure trip. On 4/5/21 she had headache, dizziness/lightheadedness, and did not feel well, and her systolic BP was 198, after which she took additional 40 mg of lisinopril.   Her BP subsequently decreased to systolic BP of 130 mm Hg on 4/5/21, but over the next few days she had labile BP with a range of BP of 125 to 171/ 58 - 68.  She was meticulous in checking and recording her BP several times a day, and she increased her lisinopril dose to 40 mg po qd from 20 mg po qd given the higher than usual blood pressure range.  On 4/10/21 her BP was as follows: 6:30 am, 148/60 (she took her daily lisinopril 20 mg po); 11:30 am:  132/52; 3 pm: 171/69 (she took additional lisinopril 20 mg po) after which her systolic BP decreased to 130. Then around 6:20 pm the same day (4/10/21), she had acute onset of headache, vomiting, left sided weakness, SBP 220, and was witnessed to have rapid change in mental status. There was no antecedent trauma to the head. EMTs were called immediately and she had loss of consciousness during the ambulance ride to the ED, after about 20 minutes of symptom onset, with agonal breathing and bradycardia to the 40s, but never lost her pulse. Upon arrival to the ED out of the country, her Glascow Coma Scale (GCS) was 6, she was rapidly intubated and stabilized. Head CT demonstrated massive intraparenchymal hemorrhage (140 cc) within the R temporal parietal and occipital lobes, with cerebral edema and 14 mm midline shift, associated with small subdural hematoma and small intraventricular hemorrhage within the temporal horn and body of the R lateral ventricle. They reported hyperdense "spot sign" within the intraparenchymal hematoma compatible with active hemorrhage, no evidence of venous thrombosis, no masses, no arteriovenous malformations. She had 2.5 mm aneurysm right  that was thought to be incidental finding unrelated to her event. She was taken emergently to the OR on 4/10/2021 for decompressive R hemicraniectomy, which she underwent successfully with minimal blood loss.  She had no coagulopathy and her platelets and hemoglobin were normal. She remained in the Neuro ICU for 3 weeks. She received a tracheostomy two weeks after her presentation, and was weaned off the ventilator. She is breathing spontaneously after 5 weeks from presentation. She remains in coma or minimally conscious state, with GCS score of 5-6 as of 5/13/2021.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Intraventricular haemorrhage, Ischaemic cerebral infarction, Labile blood pressure, Left ventricular hypertrophy, Loss of consciousness
Clinical narrative: Patient is an 80 y/o right handed female who is totally independent at baseline who received her Pfizer vaccine out of the country (1st dose 2/19/21, 2nd dose 3/12/21).  She was reactive to both shots, reporting arthralgias, headache, low grade fever, chills. She had a rise in blood pressure later during the day of her shot as well as the next day (up to 180/70, from baseline of 130/70). She also had an episode of epistaxis several days after her first shot.  She traveled independently out of the country on 3/31/21 to visit her son on a leisure trip. On 4/5/21 she had headache, dizziness/lightheadedness, and did not feel well, and her systolic BP was 198, after which she took additional 40 mg of lisinopril.   Her BP subsequently decreased to systolic BP of 130 mm Hg on 4/5/21, but over the next few days she had labile BP with a range of BP of 125 to 171/ 58 - 68.  She was meticulous in checking and recording her BP several times a day, and she increased her lisinopril dose to 40 mg po qd from 20 mg po qd given the higher than usual blood pressure range.  On 4/10/21 her BP was as follows: 6:30 am, 148/60 (she took her daily lisinopril 20 mg po); 11:30 am:  132/52; 3 pm: 171/69 (she took additional lisinopril 20 mg po) after which her systolic BP decreased to 130. Then around 6:20 pm the same day (4/10/21), she had acute onset of headache, vomiting, left sided weakness, SBP 220, and was witnessed to have rapid change in mental status. There was no antecedent trauma to the head. EMTs were called immediately and she had loss of consciousness during the ambulance ride to the ED, after about 20 minutes of symptom onset, with agonal breathing and bradycardia to the 40s, but never lost her pulse. Upon arrival to the ED out of the country, her Glascow Coma Scale (GCS) was 6, she was rapidly intubated and stabilized. Head CT demonstrated massive intraparenchymal hemorrhage (140 cc) within the R temporal parietal and occipital lobes, with cerebral edema and 14 mm midline shift, associated with small subdural hematoma and small intraventricular hemorrhage within the temporal horn and body of the R lateral ventricle. They reported hyperdense "spot sign" within the intraparenchymal hematoma compatible with active hemorrhage, no evidence of venous thrombosis, no masses, no arteriovenous malformations. She had 2.5 mm aneurysm right  that was thought to be incidental finding unrelated to her event. She was taken emergently to the OR on 4/10/2021 for decompressive R hemicraniectomy, which she underwent successfully with minimal blood loss.  She had no coagulopathy and her platelets and hemoglobin were normal. She remained in the Neuro ICU for 3 weeks. She received a tracheostomy two weeks after her presentation, and was weaned off the ventilator. She is breathing spontaneously after 5 weeks from presentation. She remains in coma or minimally conscious state, with GCS score of 5-6 as of 5/13/2021.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging head abnormal, Malaise, Mechanical ventilation, Mental status changes, Oedema
Clinical narrative: Patient is an 80 y/o right handed female who is totally independent at baseline who received her Pfizer vaccine out of the country (1st dose 2/19/21, 2nd dose 3/12/21).  She was reactive to both shots, reporting arthralgias, headache, low grade fever, chills. She had a rise in blood pressure later during the day of her shot as well as the next day (up to 180/70, from baseline of 130/70). She also had an episode of epistaxis several days after her first shot.  She traveled independently out of the country on 3/31/21 to visit her son on a leisure trip. On 4/5/21 she had headache, dizziness/lightheadedness, and did not feel well, and her systolic BP was 198, after which she took additional 40 mg of lisinopril.   Her BP subsequently decreased to systolic BP of 130 mm Hg on 4/5/21, but over the next few days she had labile BP with a range of BP of 125 to 171/ 58 - 68.  She was meticulous in checking and recording her BP several times a day, and she increased her lisinopril dose to 40 mg po qd from 20 mg po qd given the higher than usual blood pressure range.  On 4/10/21 her BP was as follows: 6:30 am, 148/60 (she took her daily lisinopril 20 mg po); 11:30 am:  132/52; 3 pm: 171/69 (she took additional lisinopril 20 mg po) after which her systolic BP decreased to 130. Then around 6:20 pm the same day (4/10/21), she had acute onset of headache, vomiting, left sided weakness, SBP 220, and was witnessed to have rapid change in mental status. There was no antecedent trauma to the head. EMTs were called immediately and she had loss of consciousness during the ambulance ride to the ED, after about 20 minutes of symptom onset, with agonal breathing and bradycardia to the 40s, but never lost her pulse. Upon arrival to the ED out of the country, her Glascow Coma Scale (GCS) was 6, she was rapidly intubated and stabilized. Head CT demonstrated massive intraparenchymal hemorrhage (140 cc) within the R temporal parietal and occipital lobes, with cerebral edema and 14 mm midline shift, associated with small subdural hematoma and small intraventricular hemorrhage within the temporal horn and body of the R lateral ventricle. They reported hyperdense "spot sign" within the intraparenchymal hematoma compatible with active hemorrhage, no evidence of venous thrombosis, no masses, no arteriovenous malformations. She had 2.5 mm aneurysm right  that was thought to be incidental finding unrelated to her event. She was taken emergently to the OR on 4/10/2021 for decompressive R hemicraniectomy, which she underwent successfully with minimal blood loss.  She had no coagulopathy and her platelets and hemoglobin were normal. She remained in the Neuro ICU for 3 weeks. She received a tracheostomy two weeks after her presentation, and was weaned off the ventilator. She is breathing spontaneously after 5 weeks from presentation. She remains in coma or minimally conscious state, with GCS score of 5-6 as of 5/13/2021.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Platelet count normal, Prothrombin time normal, Pulmonary hypertension, Pyrexia, Subdural haematoma
Clinical narrative: Patient is an 80 y/o right handed female who is totally independent at baseline who received her Pfizer vaccine out of the country (1st dose 2/19/21, 2nd dose 3/12/21).  She was reactive to both shots, reporting arthralgias, headache, low grade fever, chills. She had a rise in blood pressure later during the day of her shot as well as the next day (up to 180/70, from baseline of 130/70). She also had an episode of epistaxis several days after her first shot.  She traveled independently out of the country on 3/31/21 to visit her son on a leisure trip. On 4/5/21 she had headache, dizziness/lightheadedness, and did not feel well, and her systolic BP was 198, after which she took additional 40 mg of lisinopril.   Her BP subsequently decreased to systolic BP of 130 mm Hg on 4/5/21, but over the next few days she had labile BP with a range of BP of 125 to 171/ 58 - 68.  She was meticulous in checking and recording her BP several times a day, and she increased her lisinopril dose to 40 mg po qd from 20 mg po qd given the higher than usual blood pressure range.  On 4/10/21 her BP was as follows: 6:30 am, 148/60 (she took her daily lisinopril 20 mg po); 11:30 am:  132/52; 3 pm: 171/69 (she took additional lisinopril 20 mg po) after which her systolic BP decreased to 130. Then around 6:20 pm the same day (4/10/21), she had acute onset of headache, vomiting, left sided weakness, SBP 220, and was witnessed to have rapid change in mental status. There was no antecedent trauma to the head. EMTs were called immediately and she had loss of consciousness during the ambulance ride to the ED, after about 20 minutes of symptom onset, with agonal breathing and bradycardia to the 40s, but never lost her pulse. Upon arrival to the ED out of the country, her Glascow Coma Scale (GCS) was 6, she was rapidly intubated and stabilized. Head CT demonstrated massive intraparenchymal hemorrhage (140 cc) within the R temporal parietal and occipital lobes, with cerebral edema and 14 mm midline shift, associated with small subdural hematoma and small intraventricular hemorrhage within the temporal horn and body of the R lateral ventricle. They reported hyperdense "spot sign" within the intraparenchymal hematoma compatible with active hemorrhage, no evidence of venous thrombosis, no masses, no arteriovenous malformations. She had 2.5 mm aneurysm right  that was thought to be incidental finding unrelated to her event. She was taken emergently to the OR on 4/10/2021 for decompressive R hemicraniectomy, which she underwent successfully with minimal blood loss.  She had no coagulopathy and her platelets and hemoglobin were normal. She remained in the Neuro ICU for 3 weeks. She received a tracheostomy two weeks after her presentation, and was weaned off the ventilator. She is breathing spontaneously after 5 weeks from presentation. She remains in coma or minimally conscious state, with GCS score of 5-6 as of 5/13/2021.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tracheostomy, Ventricular hypertrophy, Vomiting, Von Willebrand's factor activity normal, Von Willebrand's factor antigen normal
Clinical narrative: Patient is an 80 y/o right handed female who is totally independent at baseline who received her Pfizer vaccine out of the country (1st dose 2/19/21, 2nd dose 3/12/21).  She was reactive to both shots, reporting arthralgias, headache, low grade fever, chills. She had a rise in blood pressure later during the day of her shot as well as the next day (up to 180/70, from baseline of 130/70). She also had an episode of epistaxis several days after her first shot.  She traveled independently out of the country on 3/31/21 to visit her son on a leisure trip. On 4/5/21 she had headache, dizziness/lightheadedness, and did not feel well, and her systolic BP was 198, after which she took additional 40 mg of lisinopril.   Her BP subsequently decreased to systolic BP of 130 mm Hg on 4/5/21, but over the next few days she had labile BP with a range of BP of 125 to 171/ 58 - 68.  She was meticulous in checking and recording her BP several times a day, and she increased her lisinopril dose to 40 mg po qd from 20 mg po qd given the higher than usual blood pressure range.  On 4/10/21 her BP was as follows: 6:30 am, 148/60 (she took her daily lisinopril 20 mg po); 11:30 am:  132/52; 3 pm: 171/69 (she took additional lisinopril 20 mg po) after which her systolic BP decreased to 130. Then around 6:20 pm the same day (4/10/21), she had acute onset of headache, vomiting, left sided weakness, SBP 220, and was witnessed to have rapid change in mental status. There was no antecedent trauma to the head. EMTs were called immediately and she had loss of consciousness during the ambulance ride to the ED, after about 20 minutes of symptom onset, with agonal breathing and bradycardia to the 40s, but never lost her pulse. Upon arrival to the ED out of the country, her Glascow Coma Scale (GCS) was 6, she was rapidly intubated and stabilized. Head CT demonstrated massive intraparenchymal hemorrhage (140 cc) within the R temporal parietal and occipital lobes, with cerebral edema and 14 mm midline shift, associated with small subdural hematoma and small intraventricular hemorrhage within the temporal horn and body of the R lateral ventricle. They reported hyperdense "spot sign" within the intraparenchymal hematoma compatible with active hemorrhage, no evidence of venous thrombosis, no masses, no arteriovenous malformations. She had 2.5 mm aneurysm right  that was thought to be incidental finding unrelated to her event. She was taken emergently to the OR on 4/10/2021 for decompressive R hemicraniectomy, which she underwent successfully with minimal blood loss.  She had no coagulopathy and her platelets and hemoglobin were normal. She remained in the Neuro ICU for 3 weeks. She received a tracheostomy two weeks after her presentation, and was weaned off the ventilator. She is breathing spontaneously after 5 weeks from presentation. She remains in coma or minimally conscious state, with GCS score of 5-6 as of 5/13/2021.
Age: 80.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: White blood cell count increased
Clinical narrative: Patient is an 80 y/o right handed female who is totally independent at baseline who received her Pfizer vaccine out of the country (1st dose 2/19/21, 2nd dose 3/12/21).  She was reactive to both shots, reporting arthralgias, headache, low grade fever, chills. She had a rise in blood pressure later during the day of her shot as well as the next day (up to 180/70, from baseline of 130/70). She also had an episode of epistaxis several days after her first shot.  She traveled independently out of the country on 3/31/21 to visit her son on a leisure trip. On 4/5/21 she had headache, dizziness/lightheadedness, and did not feel well, and her systolic BP was 198, after which she took additional 40 mg of lisinopril.   Her BP subsequently decreased to systolic BP of 130 mm Hg on 4/5/21, but over the next few days she had labile BP with a range of BP of 125 to 171/ 58 - 68.  She was meticulous in checking and recording her BP several times a day, and she increased her lisinopril dose to 40 mg po qd from 20 mg po qd given the higher than usual blood pressure range.  On 4/10/21 her BP was as follows: 6:30 am, 148/60 (she took her daily lisinopril 20 mg po); 11:30 am:  132/52; 3 pm: 171/69 (she took additional lisinopril 20 mg po) after which her systolic BP decreased to 130. Then around 6:20 pm the same day (4/10/21), she had acute onset of headache, vomiting, left sided weakness, SBP 220, and was witnessed to have rapid change in mental status. There was no antecedent trauma to the head. EMTs were called immediately and she had loss of consciousness during the ambulance ride to the ED, after about 20 minutes of symptom onset, with agonal breathing and bradycardia to the 40s, but never lost her pulse. Upon arrival to the ED out of the country, her Glascow Coma Scale (GCS) was 6, she was rapidly intubated and stabilized. Head CT demonstrated massive intraparenchymal hemorrhage (140 cc) within the R temporal parietal and occipital lobes, with cerebral edema and 14 mm midline shift, associated with small subdural hematoma and small intraventricular hemorrhage within the temporal horn and body of the R lateral ventricle. They reported hyperdense "spot sign" within the intraparenchymal hematoma compatible with active hemorrhage, no evidence of venous thrombosis, no masses, no arteriovenous malformations. She had 2.5 mm aneurysm right  that was thought to be incidental finding unrelated to her event. She was taken emergently to the OR on 4/10/2021 for decompressive R hemicraniectomy, which she underwent successfully with minimal blood loss.  She had no coagulopathy and her platelets and hemoglobin were normal. She remained in the Neuro ICU for 3 weeks. She received a tracheostomy two weeks after her presentation, and was weaned off the ventilator. She is breathing spontaneously after 5 weeks from presentation. She remains in coma or minimally conscious state, with GCS score of 5-6 as of 5/13/2021.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Chills, shivering.  8:30Pm Fever 3;40 am  101.4  fever 7:00m am  101.2  fever 9:40 am 101.0
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain
Clinical narrative: Chills and body aches
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cardioversion, Full blood count, Lipase, Metabolic function test, Supraventricular tachycardia
Clinical narrative: Supraventricular Tachycardia, cardioversion(adenosine), released from ER after observation.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Troponin I
Clinical narrative: Supraventricular Tachycardia, cardioversion(adenosine), released from ER after observation.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Pyrexia, Vertigo, Vomiting
Clinical narrative: Severe vomiting.  Fever. Exhaustion.  Muscle aches all body. 5 days later, severe vertigo incident with vomiting. Vertigo continued one week daily basis and now continues Intermittent.  Most recent Wednesday may 12t severe and moderate Friday night May 14th
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Angioedema, Cough, Fatigue, Injection site pain, Pyrexia
Clinical narrative: - Fever (101 degrees) - 12 hours - Angioedema of the lips - 10 hours - Hives/rash on arms, body, scalp, shins,  and face - 12 hours - Extreme fatigue - 48 hours - Coughing - 48 hours - Pain at injection site - 48 hours
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: - Fever (101 degrees) - 12 hours - Angioedema of the lips - 10 hours - Hives/rash on arms, body, scalp, shins,  and face - 12 hours - Extreme fatigue - 48 hours - Coughing - 48 hours - Pain at injection site - 48 hours
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia
Clinical narrative: Extreme muscle soreness, headache, fever
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Loss of consciousness
Clinical narrative: Patient states that he felt fine for 30 mins after shot, then blacked out on his ride home and forgot the whole ride which was a bizarre experience. Then he had a horrific cough which he felt may have cracked a rib.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Pain in extremity
Clinical narrative: pain above injection site, mild below distal extremity. no swelling or discoloration. Pt. tensed up during the time of the vaccination. Ice pack applied
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Hyperhidrosis, Influenza like illness, Migraine
Clinical narrative: Sever body chills, sweats, all over body aches, no appetite, flu like symptoms, severe migraine, fever,
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Sever body chills, sweats, all over body aches, no appetite, flu like symptoms, severe migraine, fever,
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Bradycardia, Syncope
Clinical narrative: Patient did not remain seated for 15 minutes post-vaccination as instructed. He fainted and hit his head. He regained consciousness quickly, but remained diaphoretic with bradycardia. He was provided water and an icepack, and he was instructed to lay flat with legs elevated until he recovered.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus . No treatment yet. Sustained, yet varying intensities
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anticoagulant therapy, Deep vein thrombosis, Pain in extremity, Peripheral swelling, Thrombectomy
Clinical narrative: Patient received a second dose of vaccination.  2 days later noted swelling left lower extremity.  Presented to hospital.  Ultrasound confirmed extensive DVT.  Status post thrombectomy.  Placed on Xarelto.  Sent home in stable condition.  Patient returned with worsening left lower leg pain, and swelling.  Had progression of DVT.  Underwent thrombectomy.  Replaced back on Xarelto.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ultrasound scan abnormal
Clinical narrative: Patient received a second dose of vaccination.  2 days later noted swelling left lower extremity.  Presented to hospital.  Ultrasound confirmed extensive DVT.  Status post thrombectomy.  Placed on Xarelto.  Sent home in stable condition.  Patient returned with worsening left lower leg pain, and swelling.  Had progression of DVT.  Underwent thrombectomy.  Replaced back on Xarelto.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anticoagulant therapy, Blood test, Computerised tomogram abnormal, Gait disturbance, Gait inability
Clinical narrative: Patient received a second dose of vaccination.  2 days later noted swelling left lower extremity.  Presented to hospital.  Ultrasound confirmed extensive DVT.  Status post thrombectomy.  Placed on Xarelto.  Sent home in stable condition.  Patient returned with worsening left lower leg pain, and swelling.  Had progression of DVT.  Underwent thrombectomy.  Replaced back on Xarelto.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Pain in extremity, Peripheral swelling, Skin discolouration, Surgical procedure repeated
Clinical narrative: Patient received a second dose of vaccination.  2 days later noted swelling left lower extremity.  Presented to hospital.  Ultrasound confirmed extensive DVT.  Status post thrombectomy.  Placed on Xarelto.  Sent home in stable condition.  Patient returned with worsening left lower leg pain, and swelling.  Had progression of DVT.  Underwent thrombectomy.  Replaced back on Xarelto.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Thrombectomy, Thrombosis, Ultrasound Doppler abnormal
Clinical narrative: Patient received a second dose of vaccination.  2 days later noted swelling left lower extremity.  Presented to hospital.  Ultrasound confirmed extensive DVT.  Status post thrombectomy.  Placed on Xarelto.  Sent home in stable condition.  Patient returned with worsening left lower leg pain, and swelling.  Had progression of DVT.  Underwent thrombectomy.  Replaced back on Xarelto.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ear discomfort, Tinnitus
Clinical narrative: Tinnitus, ear pressure left ear.
Age: 23.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Syncope
Clinical narrative: Adult female who received her vaccine went to the observation area, became weak and faint. On site EMS that were stationed in the observation transported to local ER. EMS Staff consulted with the patients mother regarding reason to transport, she consented.
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Pyrexia
Clinical narrative: Fever over 100.4, chills, headache, dizziness Treatment- rest and fluids Time-2 days
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: Headache, Nausea. Seen by EMS on site (Rolson 489) VS: HR 104 Regular  BP: 144/97      Spo2: 99% at 11:06 Reported improved conditions- still C/O "slight nausea " HR:98  BP:127/95    SPO2:99% 11:21 Cleared by EMS-left site Discharged home at 11:25
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: pt had nothing to eat or drink today. pt. reported he was light headed. BP:122/75 HR:81 O2:98
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Dizziness, Ear pain, Head discomfort, Migraine
Clinical narrative: Woke with a migraine, dizziness, and slight nausea. I took Excedrin which usually takes care of my migraines. It knocked it back to pressure and a slight headache, but did not get rid of it entirely. I continued to be sensitive to light all day. When the pain increased that afternoon/ early evening i took another dose of Excedrin.  This continued for the next two days, the second of which I added musinex and an antihistamine in the morning because it felt like it could be sinus pressure.  These did not help and seemed to make the dizziness and nausea worse. I woke up on day 3 with a migraine and ear pain the next day and was still sensitive to light, which continued all day. I woke up on day 4 with a headache and ear pain to the point that I thought I might have an ear infection.  This time I did not take any medication. I woke up on day 5 with a headache but no other issues.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Paranasal sinus discomfort, Photophobia
Clinical narrative: Woke with a migraine, dizziness, and slight nausea. I took Excedrin which usually takes care of my migraines. It knocked it back to pressure and a slight headache, but did not get rid of it entirely. I continued to be sensitive to light all day. When the pain increased that afternoon/ early evening i took another dose of Excedrin.  This continued for the next two days, the second of which I added musinex and an antihistamine in the morning because it felt like it could be sinus pressure.  These did not help and seemed to make the dizziness and nausea worse. I woke up on day 3 with a migraine and ear pain the next day and was still sensitive to light, which continued all day. I woke up on day 4 with a headache and ear pain to the point that I thought I might have an ear infection.  This time I did not take any medication. I woke up on day 5 with a headache but no other issues.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Paraesthesia, Pruritus
Clinical narrative: Itching & tingling in face and neck, resolved with OTC Loratadine Flu like symptoms Woke up the next morning feeling totally normal
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Discomfort, Gait disturbance, Pain, Sciatica
Clinical narrative: Chronic, shooting pain in right hip / sciatic area. Painful enough to prevent sleeping / sitting / walking. I have been taking Aleve / Advil routinely since the pain started. It helps a little but doesn't completely ease the discomfort.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Sleep disorder
Clinical narrative: Chronic, shooting pain in right hip / sciatic area. Painful enough to prevent sleeping / sitting / walking. I have been taking Aleve / Advil routinely since the pain started. It helps a little but doesn't completely ease the discomfort.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Induration, Pain, Peripheral swelling, Rash
Clinical narrative: Pt reports COVID arm rash. About 4 hours after vaccine, patient's arm swole and arm was hot to the touch. About 2 hours after intial rash, it migrated down the arm. Patient reports is was about 3 inches in diameter. Pt took ibuprofen, and sat in salt bath for about 1.5 hours. After that the swelling started to reduce.  Patient has not contacted MD, due to office being closed over the weekend. Patient reports arm being hot, red, and hard, but it not itch. Any movement hurt while at the peak.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Skin warm
Clinical narrative: Pt reports COVID arm rash. About 4 hours after vaccine, patient's arm swole and arm was hot to the touch. About 2 hours after intial rash, it migrated down the arm. Patient reports is was about 3 inches in diameter. Pt took ibuprofen, and sat in salt bath for about 1.5 hours. After that the swelling started to reduce.  Patient has not contacted MD, due to office being closed over the weekend. Patient reports arm being hot, red, and hard, but it not itch. Any movement hurt while at the peak.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Tongue haemorrhage
Clinical narrative: Mild bleeding in the back of the tongue for the past two nights when brushing teeth.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Susbstantial arm pain & fatigue
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Cold sweat, Pain, Pain of skin, Skin exfoliation, Skin odour abnormal
Clinical narrative: Severe burning pain of back (skin only not internal). Two days later skin peeled off as a sunburn would. Also change in personal body odor (not unpleasant just different) - obvious to other family members not just me. It's 6 days since vaccine and I'm still feeling clammy.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Hypotension, Loss of consciousness
Clinical narrative: Patient lost consciousness for under one minute. When he lost consciousness his blood pressure dropped and he fell forward (didn't hit the floor). He was given water to bring up his blood pressure and cool rags to cool him off.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Syncope
Clinical narrative: about 1 minute after receiving vaccine patient fainted for about 30 seconds. I touched her hand and she came to. Her husband came in to be with her and we gave bottled water. She sat in chair about 15 minutes and went home with her husband
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Injection site pain, Oropharyngeal pain
Clinical narrative: Tired, minor sore throat, soreness at injection site (upper left arm)
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: According to the patient's daughter, patient started with a rash on her hand the day following her second dose of Moderna. It progressed to cover almost her entire body. She was prescribed a course of oral steroids which minimized the rash, but it returned after the course was completed. Her primary doctor referred her to a dermatologist, who at the time this form was submitted had not yet been seen, but based on the description suspected Stevens-Johnson Syndrome(SJS).
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Injection site pruritus, Injection site swelling
Clinical narrative: Fatigue Joint pain  Headache  Swelling at injection site  Itchy at injection site
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Paraesthesia, Rash
Clinical narrative: I got shingles for the first time.   I felt a tingle on my face  just below my lip the day of the vaccine on Wednesday May 12th, it continued to the next day and on the third day, May 14th I got a painful rash where the tingling was.  I went to the doctor on Saturday the 15th and was diagnosed with shingles and prescribed the antiviral Valacyclivir
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Oligomenorrhoea
Clinical narrative: Missed period that should have occurred 5/12. First missed period in lifetime.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Injection site pain, Pain, Pyrexia
Clinical narrative: Aches, fever, chills, pain at injection site, loss of appetite, unable to sleep
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Sleep disorder
Clinical narrative: Aches, fever, chills, pain at injection site, loss of appetite, unable to sleep
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling jittery, Headache
Clinical narrative: BP:128/76 HR:80 02:98 headache and jittery. strong pulse, alert, does not like crowds and the vaccine.  EMS REFUSAL
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headaches
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: SEVERE ITCHING FOR MONTHS
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain, Pyrexia
Clinical narrative: Chills, low grade fever, fatigue, body aches
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site rash, Injection site reaction
Clinical narrative: Moderna COVID-19 Vaccine   About 9 days after receiving the first shot, the injection site started itching in the evening, and by the next morning a large pink circle formed around the site and it was very warm to the touch. As of right now (Sunday afternoon, May 16) it remains the same size and color, itchy, tender, and warm.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Menstruation delayed
Clinical narrative: Period supposed to start on May 03, but it is 2 weeks late starting today on May 16.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pruritus, Pyrexia, Rash, Urticaria
Clinical narrative: Full-body rash (redness patches all over)and hives (including on face, arms, legs, back, stomach, thighs) with itching started on Wednesday after second dose on Monday, after fever/fatigue settled down (which had started on Monday and stopped by Wednesday).  No symptoms like this after first dose (expect fever headache, fatigue for 2 days which also happened after second dose).  Treatment - Taking prednisone 40 mg a day for 5 days,  Altarax once a day for 5 days.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Headache, Rhinorrhoea
Clinical narrative: Fatigue, headache, loss of appetite, runny nose Medication - Tylenol, Benadryl Next day no symptoms
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Hypoacusis, Visual impairment
Clinical narrative: PT REPORTED BEING DIZZY, SAW SPOTS, HEARING WAS MUFFLED BP: 90/70 HR:88 02:98 PT. OFFERED WATER AND WAITED IN OBSERVATION LONGER-SIGNED WAIVER AND LEFT ON THIER OWN
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Nervousness
Clinical narrative: PT REPORTED BEING DIZZY AND A HEADACHE. PATIENT REPORTED BEING NERVOUS BP: 140/80 HR:75 02:98
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Headache, Injection site pain, Malaise
Clinical narrative: Arm pain, injection site pain, diarrheah, dizziness, general feeling of unwellness, slight feverr, headache
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Arm pain, injection site pain, diarrheah, dizziness, general feeling of unwellness, slight feverr, headache
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Gastrointestinal haemorrhage
Clinical narrative: patient died aprox 1 week after the 2nd dose . presumed cause of death stated by son was GI bleed. Not confirmed to be caused by the vaccine.  Autopsy not performed according to the son.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Adverse reaction, COVID-19, COVID-19 pneumonia, Computerised tomogram abdomen abnormal
Clinical narrative: Extreme abdominal pain/cramping. We ended up taking her to the ER department at the Hospital because the pain was so extreme. In the course of the visit to the ER, they took a CT scan of the abdomen, and there saw evidence of Covid in the lungs. They did a nose swab test, and she tested positive. She had some mild symptoms (stuffy head, headache, mild sore throat) earlier in the week (May 8 - May 9), but we thought it was possibly allergies. Turns out it was Covid and we didn't know it.  It seems that with the Covid virus already in the system, the shot caused an extreme reaction.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: Extreme abdominal pain/cramping. We ended up taking her to the ER department at the Hospital because the pain was so extreme. In the course of the visit to the ER, they took a CT scan of the abdomen, and there saw evidence of Covid in the lungs. They did a nose swab test, and she tested positive. She had some mild symptoms (stuffy head, headache, mild sore throat) earlier in the week (May 8 - May 9), but we thought it was possibly allergies. Turns out it was Covid and we didn't know it.  It seems that with the Covid virus already in the system, the shot caused an extreme reaction.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Flushing, Immediate post-injection reaction, Injection site reaction, Peripheral swelling
Clinical narrative: Immediately following injection I, patient became warm and flushed. The next day an injection site reaction occurred. My arm was swollen, red, and warm for 3-5 days.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Skin warm
Clinical narrative: Immediately following injection I, patient became warm and flushed. The next day an injection site reaction occurred. My arm was swollen, red, and warm for 3-5 days.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Exposure during pregnancy, Fatigue, Nausea
Clinical narrative: Nausea, fatigue. While these were present before the vaccine due to my pregnancy and hyper gravidarum, they became significantly worse after receiving the vaccine and persisted for nearly 48 hours.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dehydration, Hyperhidrosis, Nausea
Clinical narrative: Approximately 6 hours after receiving the second dose of the Moderna Vaccine on 05/12/2021 I started having chills. This progressed through the night with a fever reaching 104.2F. After taking 750mg of acetaminophen the fever reduced to around 102F. The fever persisted at 102F accompanied by heavy perspiration for approximately 40 hours with 750mg of acetaminophen being taken every 6 hours. For about 10 more hours the fever stayed around 100F with chills and constant perspiration until dehydration set in. Nausea limited the amount of water that could be consumed ultimately resulting in mild dehydration. After fever broke I continue to have headaches through filling out this form along with sharp pains in my lower left leg on the front of the leg. I also have a lot of pain in the upper right glute as if I had been hit my something quite hard. For about 48 hours while these symptoms occurred I remained in bed and tried to drink water. I spoke with the pharmacist who administered the vaccine today and she advised me to report my symptoms right away and to follow up with my doctor on Tuesday or Wednesday if my symptoms persist.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Approximately 6 hours after receiving the second dose of the Moderna Vaccine on 05/12/2021 I started having chills. This progressed through the night with a fever reaching 104.2F. After taking 750mg of acetaminophen the fever reduced to around 102F. The fever persisted at 102F accompanied by heavy perspiration for approximately 40 hours with 750mg of acetaminophen being taken every 6 hours. For about 10 more hours the fever stayed around 100F with chills and constant perspiration until dehydration set in. Nausea limited the amount of water that could be consumed ultimately resulting in mild dehydration. After fever broke I continue to have headaches through filling out this form along with sharp pains in my lower left leg on the front of the leg. I also have a lot of pain in the upper right glute as if I had been hit my something quite hard. For about 48 hours while these symptoms occurred I remained in bed and tried to drink water. I spoke with the pharmacist who administered the vaccine today and she advised me to report my symptoms right away and to follow up with my doctor on Tuesday or Wednesday if my symptoms persist.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Ringing and buzzing in left ear.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Feeling hot, Loss of consciousness, Seizure, Syncope
Clinical narrative: Patient received her first dose of the Pfizer Covid-19 vaccine. While waiting for observation, patient started to faint and seized. She also reported being hot and asked to take off her sweater.  Paramedic was called and patient was taking to the nearby hospital.  Patient reported black out while sitting on her chair, though by the time paramedic finish with the transportation patient reported vision recovery.